$13.07
0[0.00%]
Last update: 4:00PM Get Real Time Here
Takeda Pharmaceutical
(NYSE:TAK)Takeda Pharmaceutical Stock (NYSE:TAK), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/01/2024 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.03 | $3.03 | — | $26.94B | $26.94B | — | Get Alert |
| 10/26/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.09 | $3.09 | — | $27.55B | $27.55B | — | Get Alert |
| 07/27/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.16 | $3.16 | — | $27.99B | $27.99B | — | Get Alert |
| 05/11/2023 | TAK | Takeda Pharmaceutical | FY | 2023 | $3.28 | $3.28 | — | $29.03B | $29.03B | — | Get Alert |
| 02/02/2023 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.72 | $3.72 | — | $27.84B | $27.84B | — | Get Alert |
| 10/27/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.80 | $3.80 | — | $28.46B | $28.46B | — | Get Alert |
| 07/28/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.74 | $3.74 | — | $28.49B | $28.49B | — | Get Alert |
| 05/11/2022 | TAK | Takeda Pharmaceutical | FY | 2022 | $3.99 | $3.99 | — | $30.39B | $30.39B | — | Get Alert |
| 02/03/2022 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.61 | $3.61 | — | $30.48B | $30.48B | — | Get Alert |
| 10/28/2021 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.53 | $3.53 | — | $30.22B | $30.22B | — | Get Alert |
| 07/30/2021 | TAK | Takeda Pharmaceutical | FY | 2021 | $3.59 | $3.59 | — | $30.67B | $30.67B | — | Get Alert |
| 02/04/2020 | TAK | Takeda Pharmaceutical | FY | 2019 | $3.53 | $3.72 | — | $30.15B | $30.15B | — | Get Alert |
| 10/31/2019 | TAK | Takeda Pharmaceutical | FY | 2019 | $3.33 | $3.51 | — | $29.37B | $29.37B | — | Get Alert |
FAQ
What is the most recent guidance for Takeda Pharmaceutical (TAK)?
There have been no specific sales or earnings guidance reported for Takeda Pharmaceutical in recent months.
Browse guidance and forecast on all stocks.